Search
Dyadic International Inc
DYAIAdd to Watchlist
0.769USD
-0.001-0.10%
Market hours （ET）Quotes delayed by 15 min
28.03MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-13The current earnings forecast score of Dyadic International Inc is 8.00, ranking 170 out of 387 in the Biotechnology & Medical Research industry. The average price target is 5.00, with a high of 5.00 and a low of 5.00.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
6.000
Target Price
+502.89%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Dyadic International Inc
DYAI
1
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Dyadic International Inc's expected revenue for the next quarter?
Dyadic International Inc's expected revenue is 1.62M.
What is Dyadic International Inc's price target?
Analysts forecast that Dyadic International Inc's price target is USD 5.00, with the highest forecast at USD 5.00 and the lowest forecast at USD 5.00.
How have Dyadic International IncDYAI's recent earnings per share performed?
The market expectation was USD -0.06, while Dyadic International IncDYAI's earnings per share (EPS) for the previous quarter was USD -0.05. EPS for the next quarter is expected at USD -0.03.
What is the analyst rating for Dyadic International Inc?
Based on the ratings of Dyadic International Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.